RxDoctor Payments Data

Daniel Gensler

Nurse Practitioner · Sacramento, CANPI 1184292286

Payments from drug & device makers

$4,512in general payments, 2019–2025

Across 72 payments — averaging $62.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Biosense Webster, Inc.$2K
  • Atricure, Inc.$401
  • Medtronic$393
  • Abbott$166
  • Kestra Medical Technology Services, Inc.$22
  • plus $20 from 1 others

What the payments were for

  • Travel & lodging$66315%
  • Food & beverage$3,27373%
  • Education$57613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,512 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$183,505
Medicare patients
853
Services billed
2,586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban374$463,627
XareltoRivaroxaban158$181,490
MultaqDronedarone Hcl36$44,457
EntrestoSacubitril/Valsartan16$20,839
Flecainide Acetate53$2,987
Amiodarone Hcl164$2,813
SotalolSotalol Hcl103$2,624
Metoprolol Succinate112$1,637
Dofetilide11$1,515
Diltiazem 24hr Er (Cd)Diltiazem Hcl51$1,291
Metoprolol Tartrate96$714
Sotalol AfSotalol Hcl13$659
Diltiazem 24hr ErDiltiazem Hcl13$487
Digoxin21$321
Carvedilol37$319

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →